Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 2046Neoplasms 1460Carcinoma, Non-Small-Cell Lung 1364Prostatic Neoplasms 1106Multiple Myeloma 873Leukemia, Myeloid, Acute 772Colorectal Neoplasms 713Neoplasm Metastasis 704Lung Neoplasms 697Melanoma 688Lymphoma 666Leukemia 596Lymphoma, Non-Hodgkin 593Leukemia, Lymphocytic, Chronic, B-Cell 535Ovarian Neoplasms 535Pancreatic Neoplasms 500Precursor Cell Lymphoblastic Leukemia-Lymphoma 485Recurrence 474Myelodysplastic Syndromes 425Lymphoma, Follicular 418Carcinoma, Renal Cell 412Head and Neck Neoplasms 408Glioblastoma 380Lymphoma, Large B-Cell, Diffuse 379Brain Neoplasms 376Hodgkin Disease 354Carcinoma, Hepatocellular 333Squamous Cell Carcinoma of Head and Neck 326Lymphoma, Mantle-Cell 306Sarcoma 286

Interventions

ropinirole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Restless Legs Syndrome × Clear all
NCT01138124 2017-05-30

Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)

GlaxoSmithKline

Completed
54,202 enrolled 21 charts
GastrointestinalGenitourinary

Carcinoma, Renal Cell, Diabetes Mellitus, Epilepsy, Hypertension, Kidney Neoplasms, Neuralgia, Pancreatic Neoplasms, Restless Legs Syndrome, Pancreatitis, Chronic

NCT00329602 2017-03-23

Long-term Study Of Ropinirole In Restless Legs Syndrome

GlaxoSmithKline

Phase 4 Completed
404 enrolled 19 charts
Lymphoid

Lymphoma, Follicular, Restless Legs Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡